| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |